LONA
LeonaBio, Inc.
NASDAQ: LONA · HEALTHCARE · BIOTECHNOLOGY
$9.10
+3.76% today
Updated 2026-04-30
Market cap
$78.44M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-24.70
Dividend yield
—
52W range
$2 – $14
Volume
0.1M
LeonaBio, Inc. (LONA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.48M | $-3.71M | $-24.11M | $-43.10M | $-72.47M | $-100.75M | $-97.17M | $-45.73M |
| Capital expenditures | $0.00 | $0.00 | $2.32M | $1.57M | $1.14M | $304000.00 | $33000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $196000.00 | $253000.00 | $633000.00 | $4.62M | $10.61M | $10.62M | $11.05M | $6.10M |
| Free cash flow | $-4.48M | $-3.71M | $-26.43M | $-44.67M | $-73.61M | $-101.06M | $-97.20M | $-45.73M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |